Tallent Cosmetic And Family Dentistry | |
108 Plaza Dr Albany KY 42602-1659 | |
(606) 340-0740 | |
Not Available |
Full Name | Tallent Cosmetic And Family Dentistry |
---|---|
Speciality | Dentist - General Practice |
Location | 108 Plaza Dr, Albany, Kentucky |
Authorized Official Name and Position | Steven M Tallent (OWNER) |
Authorized Official Contact | 6063400740 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Tallent Cosmetic And Family Dentistry 108 Plaza Dr Albany KY 42602-1659 Ph: (606) 340-0740 | Tallent Cosmetic And Family Dentistry 108 Plaza Dr Albany KY 42602-1659 Ph: (606) 340-0740 |
NPI Number | 1205190733 |
---|---|
Provider Enumeration Date | 06/29/2012 |
Last Update Date | 09/17/2012 |
Identifier | Type | State | Issuer |
---|---|---|---|
1205190733 | NPI | - | NPPES |
60002227 | Medicaid | KY | |
60003415 | Medicaid | KY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1223G0001X | Dentist - General Practice | (* (Not Available)) | Primary |
News Archive
Some viruses come from animals and jump to humans to cause disease. In the case of the novel coronavirus, now known as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), it is thought to have come from bats, jumped to an intermediate animal host, and then onto humans. But can the virus leap from humans to other animals?
Featured in the June edition of the Journal of Obstetrics and Gynaecology Canada is a new clinical practice guideline which suggests that carrying twins requires greater monitoring and, therefore, the more frequent use of ultrasound technology to conduct the ongoing assessment of twin pregnancies.
The U.S. Food and Drug Administration is warning that terbutaline administered by injection or through an infusion pump should not be used in pregnant women for prevention or prolonged (beyond 48-72 hours) treatment of preterm labor due to the potential for serious maternal heart problems and death. In addition, oral terbutaline tablets should not be used for prevention or treatment of preterm labor.
An experimental, biologic treatment, brodalumab, achieved 100 percent reduction in psoriasis symptoms in twice as many patients as a second, commonly used treatment, according to the results of a multicenter clinical trial led by Mount Sinai researchers and published online today in the New England Journal of Medicine.
Treating advanced melanoma patients with either a combination of the immunotherapy drugs nivolumab (Opdivo™) and ipilimumab (Yervoy™) or nivolumab alone significantly increases progression-free survival (PFS) over using ipilimumab alone, according to new findings from researchers at Memorial Sloan Kettering Cancer Center (MSK) simultaneously presented today at the American Society of Clinical Oncology (ASCO) annual meeting and published online in the New England Journal of Medicine (NEJM). Examining specific characteristics of each patient's tumor has also given researchers clearer understanding of which patients should receive the combination.
› Verified 4 days ago